Document is current
Any future updates will be listed below
-
Authors
Poolman, Jan T. https://orcid.org/0000-0002-9583-8126
Torres, Victor J. https://orcid.org/0000-0002-7126-0489
Missiakas, Dominique
Welten, Suzanne P. M. https://orcid.org/0000-0002-8224-7984
Fernandez, Jeffrey https://orcid.org/0000-0001-6950-6139
DuMont, Ashley L. https://orcid.org/0000-0002-0280-1624
O’Keeffe, Anna
Konstantinov, Sergey R.
Morrow, Brian
Burghout, Peter
Grijpstra, Jan https://orcid.org/0009-0006-4712-5267
van Beers, Miranda M. C. https://orcid.org/0009-0000-1543-6438
Anish, Chakkumkal
Beurret, Michel https://orcid.org/0000-0002-4623-8896
Geurtsen, Jeroen
Rood, Pauline M. L. https://orcid.org/0009-0006-3591-3629
Koeberling, Oliver https://orcid.org/0009-0001-7386-9255
Shi, Miaomiao
van den Dobbelsteen, Germie P. J. M. https://orcid.org/0009-0009-3703-9842
-
Funding
Funding for this research was provided by:
Janssen Vaccines & Prevention B.V
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 21 March 2025
First Online: 20 April 2025
Competing interests
: J.T.P., S.W., J.F., S.K., B.M., P.B., J.Gr., M.vB., A.C., M.B., J.Ge., O.K., P.R. and G.vdD. are employees of Janssen Vaccines & Prevention B.V., J.T.P., P.B., J.Gr., M.vB., A.C., M.B., J.Ge., P.R., G.vdD., S.W. and J.F. hold stock/shares in Johnson & Johnson Pte Ltd. J.T.P. and J.F. are inventors on patents describing LukAB variants as vaccine against S. aureus. V.J.T. and A.L.D. are inventors on patents and patent applications filed by New York University, which are currently under the commercial license to Janssen Biotech Inc. (JBIO). JBIO provides research funding and other payments associated with exclusive licensing agreements. A.O.K. no conflict. Dominique Missiakas and Miaomiao Shi are the inventors of patents describing SpA variants as vaccines against S. aureus. D.M. is the founder of ImmunArtes LLC, a University of Chicago startup company that aims to develop vaccines and therapies against S. aureus infections.
